Ulcer: all 2,013 studies

Page 13 of 21. Open to participants first (211), then studies with results posted, then the rest; newest registration first within each.

• The Role of Percutaneous Angioplasty in Ischemic Leg Ulcer HealingCompletedNCT03057080Not applicable
• The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative ColitisCompletedNCT03053713Not applicable
• DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot UlcersCompletedNCT03044132Not applicable
• Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life OutcomesStatus unknownNCT03041844Not applicable
• The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure UlcersStatus unknownNCT03038490Not applicable
• Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass GraftWithdrawnNCT03038009Phase 4
• Evaluation of ABSOLVE in Diabetic Foot UlcersStatus unknownNCT03037970Phase 2
• Thermal Imaging to Identify Distinct Temperature Patterns in Various Stages of Pressure UlcersWithdrawnNCT03034161
• Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing UlcersCompletedNCT03026855Phase 1
• EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds ManagementCompletedNCT03021811Not applicable
• Study of E6007 in Japanese Patients With Moderate Active Ulcerative ColitisCompletedNCT03018054Phase 2
• Fecal Microbiota Transplantation for Ulcerative ColitisStatus unknownNCT03016780Phase 1/2
• Treatment of Chronic Diabetic Foot Ulcers by Minimally Invasive SurgeryStatus unknownNCT03010215Not applicable
• Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic SclerosisCompletedNCT03007004Phase 2
• Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative ColitisCompletedNCT03006809Phase 1
• Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral TubingStatus unknownNCT02998112Phase 4
• Preventing Pressure Ulcers With Repositioning Frequency and Precipitating FactorsCompletedNCT02996331Not applicable
• Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot UlcersStatus unknownNCT02989961Phase 1/2
• Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUsWithdrawnNCT02988063Phase 4
• Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular FractionStatus unknownNCT02987101Not applicable
• A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)CompletedNCT02986724
• Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic PatientsCompletedNCT02986256Not applicable
• A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative ColitisCompletedNCT02985593Phase 1
• Study of VF001-DP in Patients With Chronic Venous Leg UlcersStatus unknownNCT02973893Phase 2
• The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot UlcerStatus unknownNCT02972528Phase 1/2
• Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative ColitisWithdrawnNCT02962245Phase 4
• LeucoPatch in Malleoli Ulcer StudyCompletedNCT02958072Not applicable
• Pressure Ulcer Monitoring Platform (PUMP)CompletedNCT02952664Not applicable
• Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)CompletedNCT02943538Not applicable
• Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2Status unknownNCT02943486Phase 1/2
• TruSkin®: Study for Treatment of Chronic Venous Leg UlcersTerminatedNCT02936128Phase 4
• TruSkin®: Study for the Treatment of Chronic Diabetic Foot UlcersTerminatedNCT02936115Phase 4
• The Effects of Moxibustion on Ulcerative ColitisCompletedNCT02931162Not applicable
• Effect of Hyaluronic Acid ECM on Venous UlcersSuspendedNCT02930499Not applicable
• Microbiota-targeted Diet for Pediatric UCCompletedNCT02922881Not applicable
• Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative ColitisStatus unknownNCT02922374Phase 1/2
• The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative ColitisCompletedNCT02914717
• Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's DiseaseWithdrawnNCT02913508Phase 2
• Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer PatientsWithdrawnNCT02912858Not applicable
• Mercaptopurine Therapy in Ulcerative ColitisStatus unknownNCT02910245Phase 3
• Interest of Skin Graft Pellets in the Management of Ulcers AlgicCompletedNCT02904707
• Wool-derived Keratin Dressings for Venous Leg UlcersCompletedNCT02896725Not applicable
• Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected ClinicallyStatus unknownNCT02889926Not applicable
• When Asking the Indication of a Skin Biopsy From a Patient With a Leg Ulcer in Primary Care?CompletedNCT02889913
• Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative ColitisCompletedNCT02888379Phase 2
• A Study in Patients With Venous Leg Ulcers and Measuring the Effects of Using Geko™ DeviceCompletedNCT02884323Not applicable
• Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot UlcersCompletedNCT02880592Not applicable
• Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)TerminatedNCT02878083Not applicable
• Remote Ischemic Conditioning for Treatment of Chronic WoundsStatus unknownNCT02873728Not applicable
• Prospective, Comparitive, Randomized Study of Allograft Versus Skin Substitute in Non-healing Diabetic Foot UlcersCompletedNCT02870816Not applicable
• Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With InfliximabCompletedNCT02868398
• Ulcerative Colitis Relapse Prevention by PrebioticsCompletedNCT02865707Not applicable
• Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative ColitisTerminatedNCT02864264Phase 1
• Case Series of Weekly Applications of dHACM in Treatment of Pressure UlcersCompletedNCT02861560Not applicable
• In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative ColitisStatus unknownNCT02852850
• ACTICOAT™ for the Treatment of Burns and Chronic WoundsCompletedNCT02852148Not applicable
• A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)TerminatedNCT02849951Phase 3
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedNCT02847455Phase 2/3
• Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound HealingStatus unknownNCT02845466Phase 3
• Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot UlcersCompletedNCT02844660Not applicable
• Support Surfaces to Prevent Pressure InjuriesCompletedNCT02844166Not applicable
• Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Case of Chronic Leg UlcersStatus unknownNCT02842502Not applicable
• Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet AgentsTerminatedNCT02840929Not applicable
• Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic UlcersStatus unknownNCT02838784Not applicable
• Effects of Compression in Mixed UlcersCompletedNCT02838251
• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot UlcersCompletedNCT02833389Phase 1
• CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)CompletedNCT02825914Not applicable
• TD-1473 for Active Ulcerative Colitis (UC)CompletedNCT02818686Phase 1
• Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative ColitisCompletedNCT02818543Phase 1
• The Diabetic Foot Ulcer RegistryStatus unknownNCT02813161
• Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital UlcersCompletedNCT02801305Phase 2
• A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot UlcersCompletedNCT02799121Phase 4
• TAPIRS Technique Plus Adjustable Compression System in Treatment of Venous Leg UlcersStatus unknownNCT02798445Not applicable
• Bosentan Treatment of Digital Ulcers Related to Systemic SclerosisCompletedNCT02798055
• Passive Training as a Treatment for Diabetic Foot UlcersTerminatedNCT02785198Not applicable
• Clinical Study to Assess Efficacy and Safety of a New Compression System in the Management of Venous Leg UlcersTerminatedNCT02782689Not applicable
• Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative ColitisStatus unknownNCT02772406Not applicable
• Optimising Infliximab Induction Therapy for Acute Severe Ulcerative ColitisCompletedNCT02770040Phase 4
• The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral UlcerWithdrawnNCT02769494Phase 3
• Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative ColitisStatus unknownNCT02768974Phase 2
• Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric UlcerCompletedNCT02761512Phase 3
• Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWithdrawnNCT02760615Phase 4
• A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the Treatment of Diabetic Foot UlcersCompletedNCT02750280Not applicable
• A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)CompletedNCT02749630Phase 1
• Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis (PRIMICISTIM)CompletedNCT02748590Not applicable
• Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From UlcersTerminatedNCT02742844Phase 1/2
• Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic UlcersStatus unknownNCT02742233Phase 4
• Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life ConditionsCompletedNCT02738125
• Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic SclerosisCompletedNCT02733978Not applicable
• Cost Evaluation of Venous Leg Ulcers ManagementCompletedNCT02728986Not applicable
• Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer BleedingWithdrawnNCT02724150Phase 4
• Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative ColitisStatus unknownNCT02721823Not applicable
• The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative ColitisActive, not recruitingNCT02721719
• Use of Santyl Within an Accountable Care OrganizationWithdrawnNCT02716519Phase 4
• Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1KCompletedNCT02707406Not applicable
• Efficacy of 50% Nitrous Oxide/50% Oxygen Gas Premix in Chronic Leg Ulcer DebridementCompletedNCT02696460Not applicable
• Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard RepositioningCompletedNCT02690753Not applicable
• Monitoring Physiologic Data in the Development of Pressure UlcersWithdrawnNCT02689817Not applicable
• Leptospermum Scoparium Honey and Wound Care for Pressure UlcersWithdrawnNCT02689310Phase 4
• UC-MSCs Gel Treatment Difficult Healing of Skin UlcersCompletedNCT02685722Phase 1

← Ulcer overview